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Abstract 
Caesalpinia bonducella contain flavonoid, tanin, saponin which has antidiabetic activity.  The aim of this study was to 
determine that the Caesalpinia bonducella seed extract orally reduces post-prandial blood glucose level and prevent the 
reduction of fasting insulin level in diabetic male albino rats (Rattus norvegicus). This study was a true experimental 
with pre-test post-test control group design using 24 male albino rats.  All samples were induced with streptozotocin 
which caused the destruction of β cell and nicotinamide which protected the β cell from destructions of that the 
pancreatic β-cell was not destructed entirely. The selected samples were divided into three groups: the control negative 
group was given distilled water (P0), the control positive group was given glibenclamide (P1), and the treatment group 
was given ethanolic extracts of Caesalpinia bonducella seed 500mg/kg body weight (P2).  Blood glucose and plasma 
insulin measurements were taken after 14 days of treatment. The result showed that the post-prandial blood glucose 
level of treatment group (P2) was decreased significantly, from 232,63±10,31 mg/dl to 185,50±16,00 mg/dl (P<0.001) 
whereas in P0 group, post-prandial blood glucose level was rising significantly from 223,75±17.03 mg/dl to 
267,25±17,56 mg/dl (p<0.001). In P1 group, the reduction of post-prandial blood glucose level was bigger compare to 
P2 group, which was from 228,50±11,55 mg/dl to 115,88±10,23 mg/dl (p<0.001).  Post test fasting insulin level of P2 
group was significantly different compare to other group (p<0.05). The administration of Caesalpinia bonducella seed 
extract increased the fasting insulin level although did not significant statistically (p>0.05) whereas the other group 
showed the reduction of fasting insulin level (p<0.05). It can be concluded that the administration of Caesalpinia 
bonducella seed extract orally reduced post-prandial blood glucose level and prevent reduction of fasting plasma insulin 
level in diabetic male albino rats.   
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Introduction   
The aging process in humans is 
characterized by the emergence of degenerative 
diseases due to decreased function of the 
body's organs. Diabetes mellitus type 2 is the 
most common degenerative disease. Diabetes 
mellitus type 2 is a metabolic disease 
characterized by elevated blood glucose levels 
and insulin resistance.1 The cause of this 
disease is multifactorial, with several risk 
factors including genetic, free radicals produce 
by metabolism, hormonal, diet, unhealthy 
lifestyle and lack of physical activity. Diabetes 
mellitus can be diagnosed by measuring blood 
glucose levels. 
Several modern medicine has been used 
to treat diabetes, including insulin, sulphonylurea, 
biguanide and glitazon.2 The treatment is 
primarily intended to control blood glucose 
within normal range so that complications of 
the disease does not occur. A very popular 
example for these is insulin and sulfonyl urea 
class (glibenclamide) which has been used 
widely at large scale. However, this synthetic 
drug such as glibenclamide can cause adverse 
side effects such as nausea, vomiting, 
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haematological and dermatological reactions, 
obstructive jaundice, hyponatremia, and 
weight gain. In addition, the use of biguanide 
can cause nausea, vomiting and epigastric 
pain, lactic acidosis and liver disease.3 
Nevertheless, the benefits of this drugs is far 
outweigh the possible side effects, then this 
pharmacological therapy remains the first 
choice for treating diabetes. The diabetes 
treatment without side effects remains a 
challenge that ongoing research is needed to 
find an alternative antidiabetic drugs without 
side effects. 
Diabetes treatment using herbs has 
become a worldwide alternative, including 
Indonesia. Various types of herbs have been 
identified to have an excellent benefits as 
treatment for many diseases. One herb that is 
widely used to treat diabetes is Caesalpinia 
bonducella seed. This herb is believed to have 
many health benefits, especially as an 
antidiabetic.4 Caesalpinia bonducella has been 
used in traditional Ayurvedic medicine for a 
long time. Caesalpinia bonducella derived 
from Caesalpiniaceae family has also reported 
to have a therapeutic effect as anthelmintics, 
antibacterial, antipyretic, and lately known to 
treat diabetes5. 
The antidiabetic activity of the 
Caesalpinia bonducella seed may resulted 
from the presence of flavonoids, saponins and 
tannins6. Flavonoids has been known as a 
natural antioxidant that protects β cells from 
free radical damage. Flavonoids also protects β 
cells against damage caused by oxidative 
stress as well regenerate β cells7-8. Morover, 
saponins can inhibit the transport of glucose in 
the gut by inhibiting the sodium glucose co-
transporter-1 (S-GLUT-1)7. It also known that 
tannins improve glucose and fat metabolism9. 
Previous study conducted by Jana et al., 
(2012) proved that the hidrometanol extract of 
Caesalpinia bonducella seed can decrease 
fasting glucose levels, which implied that the 
Caesalpinia bonducella seed extract can 
stimulate the pancreatic β cells to produce and 
secrete insulin, and help regeneration of 
pancreatic β cells. Caesalpinia bonducella 
extract demonstrated antihyperglycemic 
activity in a chronic model of diabetes mellitus 
type 2. This extract promotes gluconeogenesis 
thereby increasing the liver glycogen content. 
Caesalpinia bonducella seed extract also 
showed antihyperglycemic and hypolipidemic 
activity in streptozotosin-induced diabetic 
rat10. Antihyperglycemic effects may be 
caused by blocking the intestinal absorption of 
glucose5. Caesalpinia bonducella seed benefits 
in traditional medicine has been widely 
recognized empirically. However, the 
scientific evidence of this plant both to 
decrease blood glucose levels and increase 
fasting insulin levels is necessary. 
 
Materials And Methods 
This study was a true experimental 
research using completely randomized pretest-
posttest control group design11. The samples 
used were male albino rats (Rattus 
norvegicus), wistar strain, diabetes with post-
prandial blood glucose levels ≥ 135 mg / dL12, 
aged 2.5-3 months, with around 190-200 
grams weight. The number of samples used 
was calculated using Pocock formula (2008) 
and obtained a minimum sample of 6 
rats/group, so it was used a total of 18 rats. 
Rats were adapted for one week, then 
induced DM type-2 with streptozotocin and 
nicotinamide. Streptozotocin dose used in this 
study was 13mg/200g body weight and the 
dose of nicotinamide was 46mg/kg13. On day 
15th blood sample were collected 2 hours 
postpandrial through orbital sinus to examined 
the glucose and insulin levels before treatment 
(pretest). After the rats were recognized as 
diabetes with post-prandial blood glucose 
levels ≥ 135 mg/dL, the rats were divided into 
three groups: negative control group was given 
distilled water 1 cc (P0), the positive control 
group was given Glibenclamide 5mg/kg (P1), 
and the treatment group was given ethanolic 
extract of  Caesalpinia bonducella seed 
500mg/kg (P2) and treated with the 
appropriate group for two weeks. Blood 
sample were then collected 2 hours 
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postpandrial through orbital sinus to examined 
the glucose and insulin levels after treatment 
(posttest). Blood glucose levels were measured 
by glucose oxidase method using gluco tool 
M14, while fasting insulin levels were 
measured using ELISA method using Rat 
Insulin ELISA kit E0707Ra of Bioassay 
Technology Laboratory15. 
The data were analyzed statistically 
using the Statistical Package for Social 
Sciences (SPSS 17.o Version). Analysis of 
Variance (Anova) test followed by Least 
Significant Difference (LSD) for normally 
distributed data and Kruskal Wallis test 
followed by Mann-Whitney test for not 
normally distributed data were used to 
compare the effect of Caesalpinia bonducella 
seed on blood glucose and fasting insulin 
levels between groups. In addition, paired 
sample T-test for normally distributed data and 
Wilcoxon test for normally distributed data 
were used to compare the effect of 
Caesalpinia bonducella seed on blood glucose 
and fasting insulin levels within group. 
 
Results And Discussion 
Post Prandial Blood Glucose Level  
The mean pretest post-prandial blood glucose 
level of negative control group (P0) was 
223.75 ± 17 036 mg/dL, the positive control 
group (P1) was 228.50 ± 11,551 mg/dL, and 
the treatment group (P2) was 232.63 ± 10 309 
mg/dL. Anova test result showed that prior to 
the treatment given, the average of blood 
glucose levels between groups were not 
different (p> 0.05). The mean posttest post-
prandial blood glucose level of negative 
control group (P0) was 267.25 ± 17 556 
mg/dL, the positive control group (P1) was 
115.88 ± 10.232 mg/dL, and the treatment 
group (P2) was 185.50 ± 16 036 mg/dL. 
Anova test result showed that after 14 days 
treatment were given, the average blood 
glucose levels between groups were 
significantly different (p <0.001) (Table 1; 
Fig.1). 
The effect of Caesalpinia bonducella 
seed on blood glucose level within group were 
performed using paired samples t-test, showed 
a significant increase in blood glucose levels 
in the group given distilled water (P0) (p 
<0.001). Whereas the other groups, both 
positive control group was given 
Glibenclamide 5mg/kg (P1) and the treatment 
group was given ethanolic extract of  
Caesalpinia bonducella seed 500mg/kg (P2) 
showed a decrease in blood glucose levels 
significantly (p <0.001) (Table 2). These 
implied that administration Caesalpinia 
bonducella seed extract of 500 mg/kg for 14 
days can decrease blood glucose levels with an 
average of 47.13 mg/dL. However, 
glibenclamide which is the standard drug for 
diabetes were given for 2 weeks has a better 
effect in decreasing blood glucose levels of 
112.62 mg/dL. 
 
Table 1. Post Prandial Blood Glucose Level 
 
Group 
Mean 
(mg/dL) 
SD F P 
Pretest negative control group (P0) 223,75 17.036 
0.893 0,424 Pretest positive control group (P1) 228,50 11.551 
Pretest treatment group (P2) 232,63 10.309 
Posttest negative control group (P0) 267,25 17.556 
205.626 0,000 Posttest positive control group (P1) 115,88 10.232 
Posttest treatment group (P2) 185,50 16.036 
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Fig 1. Blood Glucose Levels Before (pretest) and After (posttest) Treatment 
 
 
Table 2. The Effect of Caesalpinia bonducella seed on Blood Glucose Level 
 
Group 
Blood Glucose Level (mg/dL) 
Mean 
Difference 
t P 
Pretest Posttest 
Negative control 
group (P0) 
223,75±17.036 267,25±17.556 43,50 -7,942 0,000 
Positive control group 
(P1) 
228,50±11,551 115,88±10,232 -112,62 16,072 0,000 
Treatment group (P2) 232,63±10.309 185,50±16.0 -47,13 10,060 0,000 
 
This research showed that the ethanolic 
extract of Caesalpinia bonducella seed can 
decrease post-prandial blood glucose levels 
significantly (p<0.001) compared to placebo 
by 20.25%. It is supported by research 
conducted by Prashant and Bhanudas (2011) 
which proved that the hydroalcoholic extract 
of Caesalpinia bonducella seed decreased 
blood glucose levels significantly (p <0.05) in 
normal mice, excess glucose mice and alloxan-
induced diabetic mice. Other studies also 
showed that hidromethanolic extract of 
Caesalpinia bonducella seed decreased fasting 
blood glucose levels significantly (p <0.05)16.  
The antidiabetic activity of the 
Caesalpinia bonducella seed extract may be 
generated from the active compounds content 
such as alkaloids, flavonoids, tannins, phenols 
and saponins. Photochemical analysis results 
showed that ethanol extract of Caesalpinia 
bonducella seed containing these substances6. 
Flavonoids are known as a natural antioxidant 
that protects β cells from free radical damage. 
Furthermore, previous studies have reported 
that flavonoids protected the β cells against 
damage caused by oxidative stress, and also 
regenerate β cells7. According to research 
conducted by Wibudi et al.17, flavonoid 
compounds play a role in controlling blood 
glucose level by increasing insulin secretion 
by pancreatic beta cells by increasing 
metabolism of Ca2 + and regenerate pancreatic 
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β cells. The interaction with ATP-sensitive K+ 
channels in the membrane of the β cells 
causing membrane depolarization and promote 
the opening of Ca2+ channel. With the opening 
of Ca2+ channel, the Ca2+ will enter β cells and 
then stimulate granules containing insulin and 
cause the secretion of insulin. 
Other active compounds contained in 
Caesalpinia bonducella seed extract is 
beneficial saponins that also decrease blood 
glucose. Saponin containing polycyclic 
aglykon, which has a distinctive character that 
is frothy when shaken with water and cause a 
bitter taste in plants. Saponins can inhibit the 
increase of blood glucose by inhibiting the 
activity of α-glucosidase enzyme (enzymes in 
digestive tract responsible for carbohydrates 
changes into glucose). Saponins inhibit the 
absorption of small nutrient molecules such as 
glucose by inhibiting glucose transporter 
system 18. Saponins reported to inhibit the 
transport of glucose in the gut by inhibiting the 
sodium glucose co-transporter-1 (S-GLUT-1) 7. 
Tannins are fenilik polymer substances 
capable of tanning leather and gelatin 
precipitate from the liquid. Tannins can be 
found in almost every part of the plant. 
Tannins are divided into two groups, 
hydrolyzed tannin and condensed tannin. This 
substance can be used to decrease blood 
glucose levels by elevating the metabolism of 
glucose and lipids. Tannins known to stimulate 
glucose and fat metabolism, so that the pile of 
these substances can be avoided and ultimately 
decreasing 9. Tannins also have antioxidant 
activity, and having hypoglycemic activity by 
increasing glycogenesis 19. 
 
Fasting Insulin Level  
 
The mean pretest fasting insulin level of 
negative control group (P0) was 11.174 ± 
1.865 mIU/L, the positive control group (P1) 
was 8.563 ± 1.327 mIU/L, and the treatment 
group (P2) was 8.716 ± 2.916 mIU/L. Anova 
test result showed that prior to the treatment 
given, the average of fasting insulin levels 
between groups were significantly different 
(p<0.05). However, there were no differences 
between positive control group (P1) and the 
treatment group (P2) (p>0.05). The mean 
posttest fasting insulin level of negative 
control group (P0) was 6.881 ± 4.125 mIU/L, 
the positive control group (P1) was 6.564 ± 
1.869 mIU/L, and the treatment group (P2) 
was 8.839 ± 1.114 mIU/L. Kruskal Wallis test 
result showed that after 14 days treatment 
were given, the average fasting insulin levels 
between groups were significantly different (p 
<0.05). Fasting insulin level of negative 
control group (P0) was not different from the 
positive control group (P1) (P> 0.05). Whereas 
the group treated with Caesalpinia bonducella 
seed extract had the highest level of insulin 
and significantly different compared to other 
groups (P <0.05) (Table 3; Figure 2).  
 
 
Table 3. Fasting Insulin Level 
 
Group 
Mean 
(mIU/L) 
SD F P 
Pretest negative control group (P0) 11.174a 1.865 
3.749 0.041 Pretest positive control group (P1) 8.563b 1.327 
Pretest treatment group (P2) 8.716b 2.916 
Posttest negative control group (P0) 6.881a 4.125 
7.745 0.021 Posttest positive control group (P1) 6.564a 1.869 
Posttest treatment group (P2) 8.839b 1.114 
*Difference notation (a,b) showed a statistical different (p<0.05) 
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Fig 2. Insulin Levels Before (pretest) and After (posttest) Treatment 
 
The effect of Caesalpinia bonducella 
seed on fasting insulin level within group were 
performed using Wilcoxon signed-rank test, 
showed a decrease in blood glucose levels in 
the group given distilled water (P0) and 
glibenclamide (P1) but not statistically 
significant (p> 0.05). Whereas the analysis 
using Independent sample t-test in the 
treatment group was given ethanolic extract of  
Caesalpinia bonducella seed 500mg/kg (P2) 
showed an increase in fasting insulin levels but 
not statistically significant (p>0.05) (Table 4).  
 
Table 4. The Effect of Caesalpinia bonducella seed on Fasting Insulin Level 
 
Group 
Blood Glucose Level (mg/dL) Mean 
Difference 
t p 
Pretest Posttest 
Negative control 
group (P0) 
11,174±1,865 6,881±4,125 -4.2925 -1.540 0,123 
Positive control 
group (P1) 
8,563±1,327 6,564±1,869 -1.9988 1.903 0,099 
Treatment group (P2) 8,716±2,916 8,839±1,114 0.1137 -0.093 0,928 
 
Polyphenols can protect pancreatic β 
cells from the toxic effects of free radicals that 
are produced under chronic hyperglycemia 
conditions. Polyphenols are also able to 
increase pancreatic β cell mass and keep the 
insulin content inside 20. 
The antidiabetic mechanism of 
Caesalpinia bonducella seed is remains 
unclear. According to Shukla et al. 21, 
hyperglycemia condition will lead to 
increasing number of free radicals through 
auto-oxidation of glucose, which can lead to 
stress oxidative and damage liver cells. 
Previous study proved that Caesalpinia 
bonducella seed extract has a strong 
antioxidant activity and have a protective 
effect against DNA damage caused by 
hydroxyl radicals making it useful in reducing 
the formation of free radicals as a result of 
diabetes. It seems that Caesalpinia bonducella 
seed extract can reduce the release of 
inflammatory cytokines which is causes 
insulin resistance in diabetes patient 21. 
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Research has shown that orally 
administrated of Caesalpinia bonducella seed 
extract can improve histopathologic 
characteristic of the pancreas, liver and 
kidneys of alloxan-induced diabetic rats. This 
was the background of this research that the 
pancreatic tissue repair after administration of 
Caesalpinia bonducella seed extract will 
improve β cells function and increase insulin 
level in mice. This research was also supported 
by Jana et al .16, proved that streptozotocin-
induced diabetic rats showed an improvement 
in the activity of hexokinase, glucose-6-
phosphate dehydrogenase and glucose-6-
phosphatase in the liver which are the 
biomarker controlled by insulin, so it can be 
predicted that the Caesalpinia bonducella seed 
extract can increase the synthesis or secretion 
of insulin by the pancreas through the presence 
of β-cell regeneration 22. 
The remarkable results of this study was 
the increased of fasting insulin level after 
administration of Caesalpinia bonducella seed 
extract, although not significant statistically. 
While the posttest fasting insulin level 
between group are being compared, it can be 
seen that the fasting insulin level of treatment 
group (P2) is significantly higher from those 
negative control group (P0) and the positive 
control group (P1). This indicates that the 
administration of Caesalpinia bonducella seed 
extract has a better effect maintain insulin 
levels rather than Glibenclamide. This result 
was differed from fact that Glibenclamide is 
standard antidiabetic drugs that have a 
hypoglycemic effect by increasing insulin 
levels. However, the glibenclamide in this 
study decreased blood glucose levels 
significantly (p <0.001) with decreasing 
insulin level. This can be explained as follows: 
(1) administration of sulfonylureas was 
initially lead to increased levels of insulin with 
decrease in blood glucose levels, insulin levels 
tend to return to the normal value; (2) 
administration of sulfonylureas may increase 
the sensitivity of pancreatic β cells to glucose 
by lowering levels of glucagon. The fall in 
blood glucose levels during treatment with 
sulfonylureas was also associated with reduced 
hepatic glucose production due to the 
decreasing glucagon level 23. 
The different result of this result with 
previous study in term of  insulin levels, can 
be caused by several factors. Firstly, the 
difference in content of Caesalpinia 
bonducella seed extract gorek grown in 
Indonesia and India 16, 22. Results of 
phytochemical analysis performed in this 
study showed no content of triterpenoids on 
Caesalpinia bonducella seed extract while the 
two previous studies found the substance. 
Secondly, Caesalpinia bonducella seed extract 
administered orally does not directly affect the 
levels of insulin but have a protective effect on 
normal pancreatic β-cells. This was evidenced 
by the persistence of fasting insulin levels in 
the group given Caesalpinia bonducella seed 
extract while the other groups tend to 
decreased. 
The mean fasting insulin levels after 
treated with Caesalpinia bonducella seed 
extract showed an improvement, although not 
statistically significant. Further research needs 
to be done with a longer time, more samples 
and increasing dose so that the results would 
show a statistically signifikan increase in 
insulin level. 
 
Conclusion 
Based on the results of this study, it can 
be concluded that the administration of 500 
mg/kg Caesalpinia bonducella seed extract 
orally can decrease post-prandial blood 
glucose levels in diabetic rats by 20.25%. The 
administration of 500mg/kg Caesalpinia 
bonducella seed extract orally also prevent a 
decrease in fasting insulin levels of diabetic 
rats compared to glibenclamide and placebo 
groups. 
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